首页 | 本学科首页   官方微博 | 高级检索  
     


Clinico-pathologic findings in medullary cystic kidney disease type 2
Authors:Anthony J. Bleyer  Thomas C. Hart  Mark C. Willingham  Samy S. Iskandar  Michael C. Gorry  Howard Trachtman
Affiliation:(1) Section on Nephrology, Wake Forest University School of Medicine, Medical Center Blvd., Winston-Salem, NC, USA;(2) National Institute of Dental and Cranio-Facial Research, National Institutes of Health, Bethesda, MD, USA;(3) Department of Pathology, Wake Forest University School of Medicine, Winston-Salem, NC, USA;(4) Division of Oral Biology, University of Pittsburgh School of Dental Medicine, Pittsburgh, PA, USA;(5) Division of Nephrology, Schneider Children"rsquo"s Hospital, New Hyde Park, NY, USA
Abstract:Medullary cystic kidney disease type 2 is an uncommon autosomal dominant condition characterized by juvenile onset hyperuricemia, precocious gout and chronic renal failure progressing to end-stage renal disease in the 4th through 7th decades of life. A family suffering from this condition is described. The patient in the index case presented with renal insufficiency as a child. A renal biopsy revealed tubular atrophy, and immunohistochemical staining of the tissue for uromodulin (Tamm Horsfall protein) revealed dense deposits in renal tubular cells. Genetic testing revealed a single nucleotide mutation (c.899G>A) resulting in an exchange of a cysteine residue for tyrosine (C300Y). Medullary cystic kidney disease type 2 (also known as uromodulin-associated kidney disease) likely represents a form of endoplasmic reticulum storage disease, with deposition of the abnormal uromodulin protein in the endoplasmic reticulum, leading to tubular cell atrophy and death.
Keywords:Uromodulin-associated kidney disease  Familial juvenile hyperuricemic nephropathy  Tamm Horsfall protein  Uromodulin
本文献已被 PubMed SpringerLink 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号